Skip to search formSkip to main contentSkip to account menu

infliximab-dyyb 100 MG Injection

Known as: INFLIXIMAB-DYYB 100MG/VIL INJ,LYPHL, INFLIXIMAB-DYYB 100MG/VIL INJ,LYPHL [VA Product], INFLIXIMAB-DYYB 100MG/VIL LYPHL INJ 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (1)

Immunosuppressive Agents
Injectioninfliximab-dyyb

Narrower (1)

infliximab-dyyb 100 MG Injection [Inflectra]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Comparative effectiveness of the biosimilar CT-P13.
The first biosimilar infliximab, CT-P13 (infliximab-dyyb) has been used for the treatment of inflammatory diseases for 4 years… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)